The Beachbody Company, Inc. Stock

Equities

BODY

US0734633094

Internet Services

Delayed Nyse 09:32:44 2024-05-20 am EDT 5-day change 1st Jan Change
9.1 USD +0.44% Intraday chart for The Beachbody Company, Inc. -2.47% +9.77%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 438M Sales 2025 * 435M Capitalization 62.26M
Net income 2024 * -53M Net income 2025 * -39M EV / Sales 2024 * 0.14 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.14 x
P/E ratio 2024 *
-1.16 x
P/E ratio 2025 *
-1.56 x
Employees 582
Yield 2024 *
-
Yield 2025 *
-
Free-Float 53.79%
More Fundamentals * Assessed data
Dynamic Chart
The Beachbody Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : The Beachbody Company, Inc., Q1 2024 Earnings Call, May 06, 2024
The Beachbody Company, Inc. Provides Earnings Guidance for Second Quarter Ending June 30, 2024 CI
The Beachbody Company, Inc and Dr. B Partner to Enable Pre-Tax Reimbursement for BODi Fitness Solutions in All 50 States CI
Beachbody Amends Financial Covenants of Term Loan with Blue Torch MT
The Beachbody Company, Inc. Announces Amendments to Its Term Loan CI
The Beachbody Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : The Beachbody Company, Inc., Q4 2023 Earnings Call, Mar 11, 2024
Earnings Flash (BODI) THE BEACHBODY COMPANY Reports Q4 Revenue $119M, vs. Street Est of $108.8M MT
The Beachbody Company, Inc. Reports Impairment of Goodwill and Intangible Assets for the Fourth Quarter Ended December 31, 2023 CI
The Beachbody Company, Inc. Provides Earnings Guidance for the First Quarter of 2024 CI
The Beachbody Company, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
The Beachbody Company, Inc. Announces Leaseback Agreement Further Strengthening Liquidity Position CI
An unknown buyer acquired Van Nuys production facility from The Beachbody Company, Inc. for $6.2 million. CI
The Beachbody Company, Inc. will Change its Ticker to BODI from BODY CI
More news
1 day+4.86%
1 week-3.92%
Current month-4.63%
1 month+0.33%
3 months+0.44%
6 months+17.13%
Current year+9.29%
More quotes
1 week
8.36
Extreme 8.36
9.35
1 month
7.66
Extreme 7.66
10.12
Current year
6.93
Extreme 6.93
13.45
1 year
6.31
Extreme 6.31
28.50
3 years
6.31
Extreme 6.31
675.00
5 years
6.31
Extreme 6.31
910.00
10 years
6.31
Extreme 6.31
910.00
More quotes
Managers TitleAgeSince
Founder 60 97-12-31
Director of Finance/CFO 51 22-05-09
Chief Operating Officer 60 21-03-31
Members of the board TitleAgeSince
Chairman 69 23-06-14
Director/Board Member 62 21-06-24
Director/Board Member 58 21-11-23
More insiders
Date Price Change Volume
24-05-20 9.1 +0.44% 895
24-05-17 9.06 +4.86% 30,753
24-05-16 8.64 -2.59% 13,799
24-05-15 8.87 -3.17% 19,918
24-05-14 9.16 -1.82% 23,334

Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT

More quotes
The Beachbody Company, Inc. is a subscription health and wellness company. The Company's products include digital subscriptions, nutritional products and connected fitness products. Its digital subscriptions include BOD and a live interactive premium subscription, BODi. The Company's digital platforms provide a one-stop-shop for all types of fitness and nutrition content, with brands such as P90X, Insanity, 21 Day Fix, 80 Day Obsession, LIIFT4, Unstress Meditations, Portion Fix, 4 Weeks of Focus, Sure Thing, and others. The Company's nutrition-first programs, Portion Fix and 2B Mindset, teach healthy eating habits and promote healthy, sustainable weight loss. Its offerings deliver both fitness and nutritional content, and personal development mindset content. Its nutritional products include Shakeology, Beachbody Performance supplements, BEACHBARs and Bevvy supplements and others. Its digital subscription offerings are complemented by its connected fitness products acquired from Myx.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
9.06 USD
Average target price
12.33 USD
Spread / Average Target
+36.13%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW